The conceptual process of drug discovery is one that is often the result of an identified need in a defined disease area. This need represents a mandate from the marketing department of a phar- maceutical company or a breakthrough at the research level that has agreed applicability in response to a valid therapeutic demand. Although the intelligent design and development of new thera- peutic entities, as evidenced by Sir James Black's H -receptor an- 2 tagonist cimetidine (Tagamet), is intellectually satisfying, many novel drugs arise from serendipity, from the chance observation of the research scientist or the clinician, that a compound has unex- pected actions of use for the treatment of human disease states. Drugs that have been identified by this route include the antipsy- chotic chlorpromazine and the putative anxiolytic buspirone. The events surrounding the process of drug discovery and de- velopment are the theme of the present volume, which attempts to present, in a logical and lucid manner, the complexity of a process that is often naively assumed to represent nothing more than the identification of a new compound and its rapid introduction into humans, free of such complications as efficacy, selectivity, safety, bioavailability, toxicity, and need.
- | Author: Michael Williams
- | Publisher: Humana
- | Publication Date: Aug 27, 1987
- | Number of Pages: 448 pages
- | Binding: Hardback or Cased Book
- | ISBN-10: 089603108X
- | ISBN-13: 9780896031081
- Author:
- Michael Williams
- Publisher:
- Humana
- Publication Date:
- Aug 27, 1987
- Number of pages:
- 448 pages
- Binding:
- Hardback or Cased Book
- ISBN-10:
- 089603108X
- ISBN-13:
- 9780896031081